Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Meridian Medcl Drug Patent Portfolio

Meridian Medcl owns 1 orange book drug protected by 1 US patent Given below is the list of Meridian Medcl's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7811254 Autoinjector with needle depth adapter 26 Aug, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Meridian Medcl.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 12 Oct, 2022 US7811254
11.5 yr surcharge- late pmt w/in 6 mo, Large Entity 12 Oct, 2022 US7811254
Maintenance Fee Reminder Mailed
Critical
30 May, 2022 US7811254
Payment of Maintenance Fee, 8th Year, Large Entity 13 Mar, 2018 US7811254
Email Notification
Critical
10 Jun, 2016 US7811254
Change in Power of Attorney (May Include Associate POA)
Critical
10 Jun, 2016 US7811254
Correspondence Address Change
Critical
09 Jun, 2016 US7811254
Correspondence Address Change
Critical
29 Aug, 2014 US7811254
Post Issue Communication - Certificate of Correction 03 Nov, 2010 US7811254
Patent Issue Date Used in PTA Calculation
Critical
12 Oct, 2010 US7811254
Recordation of Patent Grant Mailed
Critical
12 Oct, 2010 US7811254
Email Notification
Critical
23 Sep, 2010 US7811254
Issue Notification Mailed
Critical
22 Sep, 2010 US7811254
Dispatch to FDC 02 Sep, 2010 US7811254
Email Notification
Critical
31 Aug, 2010 US7811254


Meridian Medcl's Family Patents

Meridian Medcl drugs have patent protection in a total of 4 countries. It has a significant patent presence in the US with 57.1% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Meridian Medcl Drug List

Given below is the complete list of Meridian Medcl's drugs and the patents protecting them.


1. Alsuma

Alsuma is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7811254 Autoinjector with needle depth adapter 26 Aug, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alsuma's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List